128 related articles for article (PubMed ID: 35777332)
1. Smart hypoxia-responsive transformable and charge-reversible nanoparticles for the deep penetration and tumor microenvironment modulation of pancreatic cancer.
Chen H; Guo Q; Chu Y; Li C; Zhang Y; Liu P; Zhao Z; Wang Y; Luo Y; Zhou Z; Zhang T; Song H; Li X; Li C; Su B; You H; Sun T; Jiang C
Biomaterials; 2022 Aug; 287():121599. PubMed ID: 35777332
[TBL] [Abstract][Full Text] [Related]
2. Gradient tumor microenvironment-promoted penetrating micelles for hypoxia relief and immunosuppression reversion in pancreatic cancer treatment.
Luo Y; Li C; Zhang Y; Liu P; Chen H; Zhao Z; Wang Y; Zhou Z; Song H; Su B; Li C; Li X; Zhang T; You H; Wu Y; Tian Z; Zhang S; Guo Y; Fan H; Chen Q; Jiang C; Sun T
Acta Biomater; 2023 Sep; 167():387-400. PubMed ID: 37276955
[TBL] [Abstract][Full Text] [Related]
3. Sono-promoted drug penetration and extracellular matrix modulation potentiate sonodynamic therapy of pancreatic ductal adenocarcinoma.
Xiao H; Li X; Li B; Zhong Y; Qin J; Wang Y; Han S; Ren J; Shuai X
Acta Biomater; 2023 Apr; 161():265-274. PubMed ID: 36893956
[TBL] [Abstract][Full Text] [Related]
4. Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradigm for tumor stroma reprogramming.
Zhao T; Zhang R; He Q; Zhou H; Song X; Gong T; Zhang Z
Acta Biomater; 2022 Jun; 145():122-134. PubMed ID: 35381402
[TBL] [Abstract][Full Text] [Related]
5. Sequentially Triggered Nanoparticles with Tumor Penetration and Intelligent Drug Release for Pancreatic Cancer Therapy.
He X; Chen X; Liu L; Zhang Y; Lu Y; Zhang Y; Chen Q; Ruan C; Guo Q; Li C; Sun T; Jiang C
Adv Sci (Weinh); 2018 May; 5(5):1701070. PubMed ID: 29876225
[TBL] [Abstract][Full Text] [Related]
6. Penetrating Micelle for Reversing Immunosuppression and Drug Resistance in Pancreatic Cancer Treatment.
Chen Q; Wang Q; Wang Y; Chu Y; Luo Y; You H; Su B; Li C; Guo Q; Sun T; Jiang C
Small; 2022 May; 18(18):e2107712. PubMed ID: 35285149
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic Tumor Microenvironment.
Wang K; He H
Adv Exp Med Biol; 2020; 1296():243-257. PubMed ID: 34185297
[TBL] [Abstract][Full Text] [Related]
8. Immune Cell Modulation of the Extracellular Matrix Contributes to the Pathogenesis of Pancreatic Cancer.
Ahmad RS; Eubank TD; Lukomski S; Boone BA
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34204306
[TBL] [Abstract][Full Text] [Related]
9. Codelivery Nanosystem Targeting the Deep Microenvironment of Pancreatic Cancer.
Chen X; Zhou W; Liang C; Shi S; Yu X; Chen Q; Sun T; Lu Y; Zhang Y; Guo Q; Li C; Zhang Y; Jiang C
Nano Lett; 2019 Jun; 19(6):3527-3534. PubMed ID: 31058513
[TBL] [Abstract][Full Text] [Related]
10. Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer.
Li Y; Zhao Z; Lin CY; Liu Y; Staveley-OCarroll KF; Li G; Cheng K
Theranostics; 2021; 11(5):2182-2200. PubMed ID: 33500719
[No Abstract] [Full Text] [Related]
11. Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.
Nagathihalli NS; Castellanos JA; Shi C; Beesetty Y; Reyzer ML; Caprioli R; Chen X; Walsh AJ; Skala MC; Moses HL; Merchant NB
Gastroenterology; 2015 Dec; 149(7):1932-1943.e9. PubMed ID: 26255562
[TBL] [Abstract][Full Text] [Related]
12. A size switchable nanoplatform for targeting the tumor microenvironment and deep tumor penetration.
Cun X; Li M; Wang S; Wang Y; Wang J; Lu Z; Yang R; Tang X; Zhang Z; He Q
Nanoscale; 2018 May; 10(21):9935-9948. PubMed ID: 29770822
[TBL] [Abstract][Full Text] [Related]
13. A "bulldozer" driven by anoxic bacteria for pancreatic cancer chemo-immunotherapy.
Zhang H; Wang Y; Zhu L; Qi Z; Cao K; Chang J; Hou L
J Control Release; 2023 Aug; 360():660-671. PubMed ID: 37433371
[TBL] [Abstract][Full Text] [Related]
14. A nanodrug simultaneously inhibits pancreatic stellate cell activation and regulatory T cell infiltration to promote the immunotherapy of pancreatic cancer.
Wang R; Hong K; Zhang Q; Cao J; Huang T; Xiao Z; Wang Y; Shuai X
Acta Biomater; 2023 Oct; 169():451-463. PubMed ID: 37572982
[TBL] [Abstract][Full Text] [Related]
15. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
Yang M; Li J; Gu P; Fan X
Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
[TBL] [Abstract][Full Text] [Related]
16. A biomimetic nanodrug for enhanced chemotherapy of pancreatic tumors.
Zhang F; Hu Q; Li B; Huang Y; Wang M; Shao S; Tang H; Yao Z; Ping Y; Liang T
J Control Release; 2023 Feb; 354():835-850. PubMed ID: 36627026
[TBL] [Abstract][Full Text] [Related]
17. Regulation of pancreatic cancer microenvironment by an intelligent gemcitabine@nanogel system via in vitro 3D model for promoting therapeutic efficiency.
Chen D; Zhu X; Tao W; Kong Y; Huag Y; Zhang Y; Liu R; Jiang L; Tang Y; Yu H; Hao Q; Yang X; Zou H; Chen J; Lu Y; Zhang H; Li W
J Control Release; 2020 Aug; 324():545-559. PubMed ID: 32504777
[TBL] [Abstract][Full Text] [Related]
18. A Tumor-Penetrating Nanomedicine Improves the Chemoimmunotherapy of Pancreatic Cancer.
Tong QS; Miao WM; Huang H; Luo JQ; Liu R; Huang YC; Zhao DK; Shen S; Du JZ; Wang J
Small; 2021 Jul; 17(29):e2101208. PubMed ID: 34145747
[TBL] [Abstract][Full Text] [Related]
19. Targeting cancer-associated fibroblasts by dual-responsive lipid-albumin nanoparticles to enhance drug perfusion for pancreatic tumor therapy.
Yu Q; Qiu Y; Li J; Tang X; Wang X; Cun X; Xu S; Liu Y; Li M; Zhang Z; He Q
J Control Release; 2020 May; 321():564-575. PubMed ID: 32112854
[TBL] [Abstract][Full Text] [Related]
20. Dandelion-Like Tailorable Nanoparticles for Tumor Microenvironment Modulation.
Guo Q; He X; Li C; He Y; Peng Y; Zhang Y; Lu Y; Chen X; Zhang Y; Chen Q; Sun T; Jiang C
Adv Sci (Weinh); 2019 Nov; 6(21):1901430. PubMed ID: 31728288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
